Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hodgkin Disease 50Lymphoma 45Testicular Neoplasms 13Teratoma 12HIV Infections 12Acquired Immunodeficiency Syndrome 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Non-Hodgkin 9Head and Neck Neoplasms 8Endodermal Sinus Tumor 8Testicular Germ Cell Tumor 7Sarcoma, Kaposi 7Neoplasms 7Carcinoma, Embryonal 7Seminoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Follicular 6Ovarian Neoplasms 5Ovarian Germ Cell Cancer 5Recurrence 4Neoplasms, Germ Cell and Embryonal 4Neoplasm Metastasis 4Carcinoma, Squamous Cell 4Vulvar Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Teratoma, Testicular 2Skin Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Cisplatin 13Etoposide 11Paclitaxel 8Cyclophosphamide 7Carboplatin 7Ifosfamide 6etoposide phosphate 5Granulocyte Colony-Stimulating Factor 5Gemcitabine 5pembrolizumab 4fludarabine 4Sirolimus 4Bleomycin 4fludarabine phosphate 3Sunitinib 3Oxaliplatin 3Mesna 3Melphalan 3Filgrastim 3Drug Therapy 3Brentuximab Vedotin 3Bevacizumab 3Automobiles 3130-nm albumin-bound paclitaxel 3tremelimumab 2sodium thiosulfate 2ribociclib 2pralsetinib 2pegfilgrastim 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Germ Cell and Embryonal × Bleomycin × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT01873326 2025-07-03

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
92 enrolled

Neoplasms, Germ Cell and Embryonal

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting
500 enrolled

Neoplasms, Germ Cell and Embryonal

NCT02161692 2014-06-12

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡